abstract |
The present invention provides a compound of formula (I ') or (I ") or a pharmaceutically acceptable salt thereof. The present compounds are inhibitors of the kinase enzyme activity of mammals, including ROR1 tyrosine kinase activity, which can be used to treat disorders associated with this activity. |